Asia Pacific Pharmaceutical Plastic Packaging Market Size & Outlook, 2026-2031
Asia Pacific Pharmaceutical Plastic Packaging Market Insights
- Based on Packaging Market Insights findings, the Asia Pacific Pharmaceutical Plastic Packaging Market size reached USD 4.84 Billion in 2025 and is expected to grow to USD 8.55 Billion by 2031.
- During 2026–2031, the market is forecasted to advance at a CAGR of 9.83%.
- Blister Packs represented the largest share of the By product type market in terms of size in 2025.
- Among the By product type segments, Blister Packs is forecasted to achieve the highest growth and remain the most lucrative through the forecast period.
Source: PIAnalysis Company Publications, Primary Interviews.
Other Key Findings
- Asia Pacific represented 19.76% of the global Pharmaceutical Plastic Packaging Market size in 2025.
- By 2031, United States is estimated to hold the largest position in the global market in terms of size.
- India is estimated to remain the fastest-growing market in Asia Pacific, advancing to USD 1.7 Billion by 2031.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2025 |
| Study Period | 2022-2031 |
| Historical Period | 2022-2024 |
| Forecast Period | 2026-2031 |
| Market Size In 2025 | USD 4.84 Billion |
| Market Size In 2031 | USD 8.55 Billion |
| Largest segment | Blister Packs |
| Units | Revenue in USD Billion |
| CAGR | 9.83% (2026-2031) |
| Segmnetation Covered | |
| Asia Pacific |
|
| By product type |
|
| By Material |
|
| By Drug Delivery Mode |
|
| By End User |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
Asia Pacific Pharmaceutical Plastic Packaging Market Country 2026-2031 (USD Billion)
| Asia Pacific | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|---|---|---|---|
| China | XX.x | XX.x | XX.x | 1.89 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| India | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Japan | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| South Korea | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Taiwan | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Australia | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Singapore | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| South East Asia | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: PIAnalysis Company Publications, Primary Interviews.
Asia Pacific Pharmaceutical Plastic Packaging Market By product type 2026-2031 (USD Billion)
| By product type | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|---|---|---|---|
| Blister Packs | XX.x | XX.x | XX.x | 1.2 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Plastic Bottle | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| By Product Type | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Pre-fillable Inhalers | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Syringes & Cartridges | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Ampoules & Vials | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Tubes | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Containers & Jars | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Others | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: PIAnalysis Company Publications, Primary Interviews.
Asia Pacific Pharmaceutical Plastic Packaging Market By Material 2026-2031 (USD Billion)
| By Material | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|---|---|---|---|
| Polyethylene (PE) | XX.x | XX.x | XX.x | 1.82 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Polyethylene Terephthalate (PET) | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Polyvinyl Chloride (PVC) | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Polystyrene (PS) | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Polycarbonate (PC) | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Others | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: PIAnalysis Company Publications, Primary Interviews.
Asia Pacific Pharmaceutical Plastic Packaging Market By Drug Delivery Mode 2026-2031 (USD Billion)
| By Drug Delivery Mode | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|---|---|---|---|
| Oral Drug Packaging | XX.x | XX.x | XX.x | 1.07 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Injectable Drug Packaging | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Topical Drug Packaging | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Inhalation Drug Packaging | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Ophthalmic Drug Packaging | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| By Packaging Type | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Primary Packaging | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Secondary Packaging | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Tertiary Packaging | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: PIAnalysis Company Publications, Primary Interviews.
Asia Pacific Pharmaceutical Plastic Packaging Market By End User 2026-2031 (USD Billion)
| By End User | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|---|---|---|---|
| Pharmaceutical Manufacturing Companies | XX.x | XX.x | XX.x | 1.98 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Contract Packaging Organizations (CPOs) | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Hospitals & Clinics | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Retail Pharmacies | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: PIAnalysis Company Publications, Primary Interviews.